NCT04007874View on ClinicalTrials.gov

Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine

PHASE3RecruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
MigraineMigraine;Menstrual
Interventions
DRUG

Ethinylestradiol/levonorgestrel

Ethinylestradiol/levonorgestrel 30/150 µg oral tablets once daily without a stopweek for 3 months

DRUG

Vitamin E

Vitamin E 400 IU oral capsules once daily for 3 months

Trial Locations (1)

2333 ZA

RECRUITING

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

Erasmus Medical Center
All Listed Sponsors
collaborator

Erasmus Medical Center

OTHER

collaborator

Netherlands Brain Foundation

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Leiden University Medical Center

OTHER

NCT04007874 - Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine | Biotech Hunter | Biotech Hunter